Combined Use of Dexmedetomidine and Hydrocortisone to Prevent New Onset AF After CABG Surgery

Clinical trial NCT05674253 · UNKNOWN

Trial details

NCT number: NCT05674253
Sponsor: Ain Shams University
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Atrial Fibrillation New Onset

Start date: 2022-12-25
Primary completion: 2023-06-25
Enrollment: 248

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.